Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04463004 |
|---|---|
| Brief Title: | Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation |
| First Submitted : | July 7, 2020 |
| First Submitted that Met QC Criteria : | July 7, 2020 |
| First Posted : | July 9, 2020 |
| Last Update Submitted that Met QC Criteria : | February 16, 2021 |
| Last Update Posted : | February 17, 2021 |